Chiara Miggiano
Pieve Emanuele, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Mosaic TP53 pathogenic variant in early-onset breast cancer: a case report.
Journal: Frontiers in oncology
Published: February 20, 2026
Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response.
Journal: Critical reviews in oncology/hematology
Published: September 23, 2025
Beyond failure of endocrine-based therapies in HR+/HER2 negative advanced breast cancer: What before chemotherapy? A glimpse into the future.
Journal: Critical reviews in oncology/hematology
Published: November 04, 2024
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.
Journal: The oncologist
Published: September 30, 2024
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer.
Journal: Biomedicines
Published: December 15, 2023
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Journal: Critical reviews in oncology/hematology
Published: November 01, 2023
Opportunities and Challenges of Synthetic Data Generation in Oncology.
Journal: JCO clinical cancer informatics
Published: August 03, 2023
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer.
Journal: Cancers
Published: April 26, 2023
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Journal: Nutrients
Published: December 16, 2022
HR+/HER2- de novo metastatic breast cancer: a true peculiar entity?
Journal: Drugs in context
Published: December 13, 2022
The effect of a treatment delay on outcome in metastatic renal cell carcinoma.
Journal: Urologic oncology
Published: October 05, 2018
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Journal: Anti-cancer drugs
Published: May 31, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026